{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:04:54Z","timestamp":1768478694863,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000051","name":"national human genome research institute","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"national institute on alcohol abuse and alcoholism","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"nih office of the director","doi-asserted-by":"publisher","award":["Common Fund"],"award-info":[{"award-number":["Common Fund"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HPS-1 is a genetic type of Hermansky-Pudlak syndrome (HPS) with highly penetrant pulmonary fibrosis (HPSPF), a restrictive lung disease that is similar to idiopathic pulmonary fibrosis (IPF). Hps1<jats:sup><jats:italic>ep\/ep<\/jats:italic><\/jats:sup> (pale ear) is a naturally occurring HPS-1 mouse model that exhibits high sensitivity to bleomycin-induced pulmonary fibrosis (PF). Traditional methods of administering bleomycin as an intratracheal (IT) route to induce PF in this model often lead to severe acute lung injury and high mortality rates, complicating studies focusing on pathobiological mechanisms or exploration of therapeutic options for HPSPF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To develop a murine model of HPSPF that closely mimics the progression of human pulmonary fibrosis, we investigated the pulmonary effects of systemic delivery of bleomycin in Hps1<jats:sup><jats:italic>ep\/ep<\/jats:italic><\/jats:sup> mice using a subcutaneous minipump and compared results to oropharyngeal delivery of bleomycin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our study revealed that systemic delivery of bleomycin induced limited, acute inflammation that resolved. The distinct inflammatory phase preceded a slow, gradually progressive fibrogenesis that was shown to be both time-dependent and dose-dependent. The fibrosis phase exhibited characteristics that better resembles human disease with focal regions of fibrosis that were predominantly found in peribronchovascular areas and in subpleural regions; central lung areas contained relatively less fibrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This model provides a preclinical tool that will allow researchers to study the mechanism of pulmonary fibrosis in HPS and provide a platform for the development of therapeutics to treat HPSPF. This method can be applied on studies of IPF or other monogenic disorders that lead to pulmonary fibrosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02002-z","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T11:02:58Z","timestamp":1651662178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Progressive pulmonary fibrosis in a murine model of Hermansky-Pudlak syndrome"],"prefix":"10.1186","volume":"23","author":[{"given":"Shachar","family":"Abudi-Sinreich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Bodine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadafumi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathanial J.","family":"Tolman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Tyrlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren C.","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen G.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Dorward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Wincovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Anikster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Resat","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette R.","family":"Gochuico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1697-6959","authenticated-orcid":false,"given":"May Christine V.","family":"Malicdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"2002_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1034\/j.1600-0854.2000.011103.x","volume":"1","author":"M Huizing","year":"2000","unstructured":"Huizing M, Anikster Y, Gahl WA. Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic. 2000;1:823\u201335.","journal-title":"Traffic"},{"key":"2002_CR2","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41436-020-0867-5","volume":"22","author":"P Pennamen","year":"2020","unstructured":"Pennamen P, Le L, Tingaud-Sequeira A, Fiore M, Bauters A, Van Duong BN, et al. BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome. Genet Med. 2020;22:1613\u201322.","journal-title":"Genet Med"},{"key":"2002_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2214\/ajr.179.4.1790887","volume":"179","author":"NA Avila","year":"2002","unstructured":"Avila NA, Brantly M, Premkumar A, Huizing M, Dwyer A, Gahl WA. Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies. AJR Am J Roentgenol. 2002;179:887\u201392.","journal-title":"AJR Am J Roentgenol"},{"key":"2002_CR4","first-page":"1839","volume":"13","author":"GW Vicary","year":"2016","unstructured":"Vicary GW, Vergne Y, Santiago-Cornier A, Young LR, Roman J. Pulmonary fibrosis in Hermansky-Pudlak syndrome. Ann Am Thorac Soc. 2016;13:1839\u201346.","journal-title":"Ann Am Thorac Soc"},{"key":"2002_CR5","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381:1718\u201327.","journal-title":"N Engl J Med"},{"key":"2002_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.genom.9.081307.164303","volume":"9","author":"M Huizing","year":"2008","unstructured":"Huizing M, Helip-Wooley A, Westbroek W, Gunay-Aygun M, Gahl WA. Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet. 2008;9:359\u201386.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2002_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194193","volume":"13","author":"S El-Chemaly","year":"2018","unstructured":"El-Chemaly S, O\u2019Brien KJ, Nathan SD, Weinhouse GL, Goldberg HJ, Connors JM, et al. Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation. PLoS ONE. 2018;13: e0194193.","journal-title":"PLoS ONE"},{"key":"2002_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88947","volume":"1","author":"LR Young","year":"2016","unstructured":"Young LR, Gulleman PM, Short CW, Tanjore H, Sherrill T, Qi A, et al. Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome. JCI Insight. 2016;1: e88947.","journal-title":"JCI Insight"},{"key":"2002_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1542\/peds.2012-4003","volume":"132","author":"SL Seward Jr","year":"2013","unstructured":"Seward SL Jr, Gahl WA. Hermansky-Pudlak syndrome: health care throughout life. Pediatrics. 2013;132:153\u201360.","journal-title":"Pediatrics"},{"key":"2002_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1600-0749.1998.tb00713.x","volume":"11","author":"RT Swank","year":"1998","unstructured":"Swank RT, Novak EK, McGarry MP, Rusiniak ME, Feng L. Mouse models of Hermansky Pudlak syndrome: a review. Pigment Cell Res. 1998;11:60\u201380.","journal-title":"Pigment Cell Res"},{"issue":"Suppl 8","key":"2002_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1034\/j.1600-0749.13.s8.12.x","volume":"13","author":"RT Swank","year":"2000","unstructured":"Swank RT, Novak EK, McGarry MP, Zhang Y, Li W, Zhang Q, et al. Abnormal vesicular trafficking in mouse models of Hermansky-Pudlak syndrome. Pigment Cell Res. 2000;13(Suppl 8):59\u201367.","journal-title":"Pigment Cell Res"},{"key":"2002_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1165\/rcmb.2006-0469OC","volume":"37","author":"LR Young","year":"2007","unstructured":"Young LR, Pasula R, Gulleman PM, Deutsch GH, McCormack FX. Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis. Am J Respir Cell Mol Biol. 2007;37:67\u201374.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2002_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1440-1827.2004.01626.x","volume":"54","author":"Y Yoshioka","year":"2004","unstructured":"Yoshioka Y, Kumasaka T, Ishidoh K, Kominami E, Mitani K, Hosokawa Y, et al. Inflammatory response and cathepsins in silica-exposed Hermansky-Pudlak syndrome model pale ear mice. Pathol Int. 2004;54:322\u201331.","journal-title":"Pathol Int"},{"key":"2002_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","volume":"1627","author":"T Liu","year":"2017","unstructured":"Liu T, De Los Santos FG, Phan SH. The bleomycin model of pulmonary fibrosis. Methods Mol Biol. 2017;1627:27\u201342.","journal-title":"Methods Mol Biol"},{"key":"2002_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-019-1143-0","volume":"14","author":"R Summer","year":"2019","unstructured":"Summer R, Krishna R, Schriner D, Cuevas-Mora K, Sales D, Para R, et al. Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome. Orphanet J Rare Dis. 2019;14:162.","journal-title":"Orphanet J Rare Dis"},{"key":"2002_CR16","doi-asserted-by":"crossref","unstructured":"Cinar R, Gochuico BR, Iyer MR, Jourdan T, Yokoyama T, Park JK, et al. Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis. JCI Insight. 2017; 2.","DOI":"10.1172\/jci.insight.92281"},{"key":"2002_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1165\/rcmb.2018-0147OC","volume":"62","author":"JK Park","year":"2020","unstructured":"Park JK, Coffey NJ, Bodine SP, Zawatsky CN, Jay L, Gahl WA, et al. Bleomycin induces drug efflux in lungs. A pitfall for pharmacological studies of pulmonary fibrosis. Am J Respir Cell Mol Biol. 2020;62:178\u201390.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2002_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5487\/TR.2010.26.3.217","volume":"26","author":"SN Kim","year":"2010","unstructured":"Kim SN, Lee J, Yang HS, Cho JW, Kwon S, Kim YB, et al. Dose\u2013response effects of bleomycin on inflammation and pulmonary fibrosis in mice. Toxicol Res. 2010;26:217\u201322.","journal-title":"Toxicol Res"},{"key":"2002_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1164\/rccm.201207-1206OC","volume":"186","author":"LR Young","year":"2012","unstructured":"Young LR, Gulleman PM, Bridges JP, Weaver TE, Deutsch GH, Blackwell TS, et al. The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med. 2012;186:1014\u201324.","journal-title":"Am J Respir Crit Care Med"},{"key":"2002_CR20","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.4049\/jimmunol.1701442","volume":"200","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, He CH, Yang DS, Nguyen T, Cao Y, Kamle S, et al. Galectin-3 interacts with the CHI3L1 axis and contributes to Hermansky-Pudlak syndrome lung disease. J Immunol. 2018;200:2140\u201353.","journal-title":"J Immunol"},{"key":"2002_CR21","doi-asserted-by":"crossref","unstructured":"Walters DM, Kleeberger SR. Mouse models of bleomycin-induced pulmonary fibrosis. Curr Protoc Pharmacol 2008, Chapter 5:Unit 5 46.","DOI":"10.1002\/0471141755.ph0546s40"},{"key":"2002_CR22","doi-asserted-by":"publisher","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","volume":"306","author":"R Lee","year":"2014","unstructured":"Lee R, Reese C, Bonner M, Tourkina E, Hajdu Z, Riemer EC, et al. Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2014;306:L736-748.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2002_CR23","unstructured":"Lam A, Herzog E, D M, J S, Gan Y, Raparia R, et al. Distinct patterns of pulmonary injury and fibrosis induced by intratracheal and subcutaneous bleomycin in the mouse: relevance for distinct forms of human lung fibrosi. In: Robertson L (ed) In cystic and idiopathic pulmonary fibrosis: risk factors, management and long-term health outcomes. USA: Nova Science Publishers; 2016. pp. 127\u2013152"},{"key":"2002_CR24","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1164\/rccm.200901-0023OC","volume":"180","author":"FN Rouhani","year":"2009","unstructured":"Rouhani FN, Brantly ML, Markello TC, Helip-Wooley A, O\u2019Brien K, Hess R, et al. Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1. Am J Respir Crit Care Med. 2009;180:1114\u201321.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02002-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02002-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02002-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T11:19:25Z","timestamp":1651663165000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02002-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02002-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments in mice were done accordance with NIH guidelines and approved by the NHGRI Animal Care and Use Committee (ACUC), under the protocol \u201cMouse models for disorders of lysosomes and lysosomal-related organelles\u201d, with the approved proposal number, G-14-3.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving animals"}}],"article-number":"112"}}